Jelly Roll's weight loss journey hasn't been easy. In an interview with Men's Health, published Jan. 2, the country crooner, 41, detailed how he went from 540 pounds, his highest weight, to 265 pounds ...

Data center construction is increasingly becoming a political issue, with locals organizing against major tech companies like Meta, Amazon and Google, which are spending billions in a push to create ...

Double-digit purchase application growth in 2025 did not lead to a major home sales rebound. Lower rates helped, but sales stayed close to 2024’s low levels. AI Summary Purchase application data had ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min After pulling its proposal for a ...

As Eli Lilly (NYSE: LLY) and Novo Nordisk (Nasdaq Copenhagen: NOVO-B) scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, a much smaller potential rival ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

A battery usually sits inside a machine like dead weight. It stores energy, but it does not help a car drive straighter, an aircraft stay aloft, or a phone survive a fall. Now, a team of researchers ...

Derik Queen turns 21 in less than three weeks. Players his age aren’t supposed to be this good this soon. They aren't supposed to put up numbers like the ones he put up Monday night at the Smoothie ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Snowflake remains well-positioned as the leading pure-play cloud data warehouse provider, benefiting from a robust cloud market and rising data volumes. SNOW's competitive edge stems from multi-cloud ...